Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines

Dube,Syamalima; Thomas,Anish; Abbott,Lynn; Benz,Patricia; Mitschow,Charles; Dube,Dipak K.; Poiesz,Bernard J.

doi:10.3892/or.2016.4732

Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines

Authors:
- Syamalima Dube
- Anish Thomas
- Lynn Abbott
- Patricia Benz
- Charles Mitschow
- Dipak K. Dube
- Bernard J. Poiesz
View Affiliations

Affiliations: Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA
Published online on: April 4, 2016 https://doi.org/10.3892/or.2016.4732
Pages: 3143-3150
Copyright: © Dube et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In humans, four tropomyosin genes (TPM1, TPM2, TPM3, and TPM4) are known to produce a multitude of isoforms via alternate splicing and/or using alternate promoters. Expression of tropomyosin has been shown to be modulated at both the transcription and the translational levels. Tropomyosins are known to make up some of the stress fibers of human epithelial cells and differences in their expression has been demonstrated in malignant breast epithelial cell lines compared to ‘normal’ breast cell lines. We have recently reported the expression of four novel TPM1 isoforms (TPM1λ, TPM1µ, TPM1ν, and TPM1ξ) from human malignant tumor breast cell lines that are not expressed in adult and fetal cardiac tissue. Also, we evaluated their expression in relation to the stress fiber formation. In this study, nine malignant breast epithelial cell lines and three ‘normal’ breast cell lines were examined for stress fiber formation and expression of tropomyosin 2 (TPM2) isoform-specific RNAs and proteins. Stress fiber formation was assessed by immunofluorescence using Leica AF6000 Deconvolution microscope. Stress fiber formation was strong (++++) in the ‘normal’ cell lines and varied among the malignant cell lines (negative to +++). No new TPM2 gene RNA isoforms were identified, and TPM2β was the most frequently expressed TPM2 RNA and protein isoform. Stress fiber formation positively correlated with TPM2β RNA or protein expression at high, statistically significant degrees. Previously, we had shown that TPM1δ and TPM1λ positively and inversely, respectively, correlated with stress fiber formation. The most powerful predictor of stress fiber formation was the combination of TPM2β RNA, TPM1δ RNA, and the inverse of TPM1λ RNA expression. Our results suggest that the increased expression of TPM1λ and the decreased expression of TPM1δ RNA and TPM2β may lead to decreased stress fiber formation and malignant transformation in human breast epithelial cells.

View Figures

View References

1	Gunning P, O'Neill G and Hardeman E: Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev. 88:1–35. 2008. View Article : Google Scholar : PubMed/NCBI
2	Lees-Miller JP and Helfman DM: The molecular basis for tropomyosin isoform diversity. BioEssays. 13:429–437. 1991. View Article : Google Scholar : PubMed/NCBI
3	Perry SV: Vertebrate tropomyosin: Distribution, properties and function. J Muscle Res Cell Motil. 22:5–49. 2001. View Article : Google Scholar : PubMed/NCBI
4	Pieples K and Wieczorek DF: Tropomyosin 3 increases striated muscle isoform diversity. Biochemistry. 39:8291–8297. 2000. View Article : Google Scholar : PubMed/NCBI
5	Pittenger MF, Kazzaz JA and Helfman DM: Functional properties of non-muscle tropomyosin isoforms. Curr Opin Cell Biol. 6:96–104. 1994. View Article : Google Scholar : PubMed/NCBI
6	Wieczorek DF: Regulation of alternatively spliced α-tropomyosin gene expression by nerve extract. J Biol Chem. 263:10456–10463. 1988.PubMed/NCBI
7	Dube DK, McLean MD, Zajdel RW, Dube S and Poiesz BJ: Does non-coding RNA play a critical role in sarcomeric tropomyosin expression and subsequent myofibrillogenesis in axolotl heart? J Clin Exp Cardiolog. 4:e1322013.
8	Dube DK, McLean MD, Dube S and Poiesz BJ: Translational control of tropomyosin expression in vertebrate hearts. Anat Rec (Hoboken). 297:1585–1595. 2014. View Article : Google Scholar
9	Franzén B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H and Auer G: Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer. 73:909–913. 1996. View Article : Google Scholar : PubMed/NCBI
10	Bharadwaj S and Prasad GL: Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett. 183:205–213. 2002. View Article : Google Scholar : PubMed/NCBI
11	Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, Salomon D and Prasad GL: Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res. 279:40–51. 2002. View Article : Google Scholar : PubMed/NCBI
12	Bharadwaj S, Hitchcock-DeGregori S, Thorburn A and Prasad GL: N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1. J Biol Chem. 279:14039–14048. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H and Helfman DM: A critical role of tropomyosins in TGF-β regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell. 15:4682–4694. 2004. View Article : Google Scholar : PubMed/NCBI
14	Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
15	Helfman DM, Flynn P, Khan P and Saeed A: Tropomyosin as a regulator of cancer-cell transformation. Tropomyosin. Gunning P: Springer; Berlin: pp. 124–131. 2008, View Article : Google Scholar
16	Dube S, Yalamanchili S, Lachant J, Abbott L, Benz P, Mitschow C, Dube DK and Poiesz BJ: Expression of tropomyosin 1 gene isoforms in human breast cancer cell lines. Int J Breast Cancer. 2015(859427)2015. View Article : Google Scholar : PubMed/NCBI
17	Dube S, Yalamanchili S, Lachant J, Abbott L, Benz P, Dube DK and Poiesz BJ: Expression of tropomyosin 2 gene isoforms in human cardiac tissue. Int J Cardiol Res. 1(301)2014.
18	Pinnamaneni S, Dube S, Welch C, Shrestha R, Benz P, Abbott L, Poiesz BJ and Dube DK: Effect of Shz-1, a cardiogenic small molecule, on expression of tropomyosin in axolotl hearts. Am Based Res J. 2:24–40. 2013.
19	Thomas A, Rajan S, Thurston HL, Masineni SN, Dube P, Bose A, Muthu V, Dube S, Wieczorek DF, Poiesz BJ, et al: Expression of a novel tropomyosin isoform in axolotl heart and skeletal muscle. J Cell Biochem. 110:875–881. 2010. View Article : Google Scholar : PubMed/NCBI
20	Denz CR, Zhang C, Jia P, Du J, Huang X, Dube S, Thomas A, Poiesz BJ and Dube DK: Absence of mutation at the 5′-upstream promoter region of the TPM4 gene from cardiac mutant axolotl (Ambystoma mexicanum). Cardiovasc Toxicol. 11:235–243. 2011. View Article : Google Scholar : PubMed/NCBI
21	Tojkander S, Gateva G and Lappalainen P: Actin stress fibers - assembly, dynamics and biological roles. J Cell Sci. 125:1855–1864. 2012. View Article : Google Scholar : PubMed/NCBI
22	Prasad GL, Fuldner RA and Cooper HL: Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA. 90:7039–7043. 1993. View Article : Google Scholar : PubMed/NCBI
23	Braverman RH, Cooper HL, Lee HS and Prasad GL: Anti-oncogenic effects of tropomyosin: Isoform specificity and importance of protein coding sequences. Oncogene. 13:537–545. 1996.PubMed/NCBI
24	Prasad GL, Masuelli L, Raj MH and Harindranath N: Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene. 18:2027–2031. 1999. View Article : Google Scholar : PubMed/NCBI